The market for Amniocentesis is expected to grow during the forecast period. Certain factors that are responsible for the growth of this market are the growing median age of first-time motherhood, the increasing burden of the congenital diseases, and the high reliability of people on amniocentesis.

Amniocentesis is almost 99.4% accurate and this test determines if the baby in the womb has any genetic or chromosomal abnormalities. The test can identify many genetic disorders, such as Down syndrome, Edward’s syndrome, Tay-Sachs disease, Huntington’s disease, Sickle cell disease, and cystic fibrosis. It can provide the information needed to diagnosis these complications in the fetus. Due to the high reliability of the test, the market is expected to expand during the forecast period.

Key Market Trends

Amniocentesis Procedure is Expected to Show Steady Growth Over the Forecast Period

According to the American Association for Clinical Chemistry, it has been observed that more than 20,000 amniocentesis procedures are performed in the United States alone every year. Rising concern about genetic disorders is the major factor responsible for the growing number of procedures. The use of amniocentesis is done since 1970. Majorly, it is being used for prenatal diagnosis of genetic disease and neural tube defects.

Various studies have been conducted by organizations such as the National Institute of Health (NIH) to understand the risks associated with amniocentesis procedure and the challenges during the same. Studies have revealed that the occurrence of early abortion after amniocentesis is a major risk and around its prevalence is around 10%. However, due to the technical advancements in the needles and the focus of medical professionals on the safety of the patient, it is expected that the chances of early abortions will be reduced in the near future.

Therefore, due to the rising number of amniocentesis procedures, growing adoption of the same and increasing focus on patient safety, the amniocentesis procedure segment is expected to show steady growth over the forecast period.

North America to Maintain Lead in the Amniocentesis Market

The global amniocentesis needle market is dominated by North America and Europe respectively. North America will continue to dominate the global market during the forecast period. Factors, such as the rising government initiatives and an increasing number of amniocentesis procedures, are driving the growth of the market in this region.

The developed healthcare system in the United States is augmenting the demand for advanced products which is accelerating the growth of amniocentesis needles with advanced technology. Added to that, a concern of the general population in North America region about the genetic disorders in a newborn is propelling the demand for amniocentesis procedure.

Competitive Landscape

The market for amniocentesis needles is moderately competitive and is comprised mostly of local companies. Countries like China and India are having a large number of local suppliers for the amniocentesis needles which is posing an intense competition among these local companies. The market is also witnessing the presence of global companies but the competition among the big players is comparatively lower than that of the local players.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client’s requirements
  • 3 months of analyst support